Skip to main content
. Author manuscript; available in PMC: 2020 May 22.
Published in final edited form as: Ann Surg Oncol. 2011 Apr;18(4):939–945. doi: 10.1245/s10434-010-1392-6

Table 1.

Patient characteristics

Characteristic Received IORT n=71 (%) no IORT n=18(%)

Mean age (range) 64.8 (48–92) 65.9 (48–83)
Clinical Staging
 cT1a 2 (2.8%) 3 (17%)
 cT1b 18 (25%) 9 (50%)
 cT1c 35 (49%) 4 (22%)
 cT2 (<3cm) 16 (23%) 2 (11%)
 cN0 89 (100%)
Grade
 I 25 (35%) 5 (28%)
 II 24 (34%) 9 (50%)
 III 22 (31%) 4 (22%)
Markers
 ER+ 56 (79%) 15 (83%)
 PR+ 49 (69%) 10 (56%)
 HER2+ 7 (10%) 1 (5.6%)
 ER+, PR+, HER2− 46 (65%) 10 (56%)
 “triple negative” 12 (17%) 2 (11%)